Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 February 2007

Volume 195, Number 4
The Journal of Infectious Diseases 2007;195:502–510
0022-1899/2007/19504-0007$15.00
DOI: 10.1086/510532
MAJOR ARTICLE

DNA Sequence Variability in Isolates Recovered from Patients with Postvaccination Rash or Herpes Zoster Caused by Oka Varicella Vaccine

Vladimir N. Loparev,1

Elena Rubtcova,1

Jane F. Seward,1

Myron J. Levin,2 and

D. Scott Schmid1

1National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; 2Section of Pediatric Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine, Denver

Little is known about the pathogenic potential of individual strains in the varicella vaccine. We analyzed genomic variation among specimens obtained from vaccine recipients with postvaccination rash or herpes zoster (HZ), focusing on polymorphisms between live attenuated varicella vaccine virus and wild‐type varicella‐zoster virus. Eleven of 18 postvaccination HZ specimens contained >1 strain, and 7 of 18 appeared to be clonal. All 21 postvaccination rash specimens contained mixtures of vaccine strains. Four single‐nucleotide polymorphisms (SNPs) consistently occurred in every isolate; all were polymorphisms in open‐reading frame (ORF) 62, and 2 confer amino acid substitutions in the immediate‐early protein 62. Four wild‐type SNPs occurred in every isolate: one each occurred in ORF 10, ORF 21, ORF 62, and a noncoding region upstream of ORF 64. The frequencies of the remaining wild‐type SNPs were variable, with the SNPs uniformly expressed (even in mixtures) in 20.5%–97.4% of isolates (mean frequency, 67.7%). No 2 clinical isolates had identical SNP profiles; as such, vaccine latency usually involves >1 strain.

Received 5 May 2006; accepted 9 August 2006; electronically published 10 January 2007.

Reprints or correspondence: D. Scott Schmid, Herpesvirus Group and National VZV Laboratory, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS G‐18, Atlanta, GA 30333 ().

Cited by

Ruth Harbecke, Michael N. Oxman, Beth A. Arnold, Charlotte Ip, Gary R. Johnson, Myron J. Levin, Lawrence D. Gelb, Kenneth E. Schmader, Stephen E. Straus, Hui Wang, Peter F. Wright, Constance T. Pachucki, Anne A. Gershon, Robert D. Arbeit, Larry E. Davis, Michael S. Simberkoff, Adriana Weinberg, Heather M. Williams, Carol Cheney, Luba Petrukhin, Katalin G. Abraham, Alan Shaw, Susan Manoff, Joseph M. Antonello, Tina Green, Yue Wang, Charles Tan, Paul M. Keller, . (2009) A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. Journal of Medical Virology 81:7, 1310-1322
Online publication date: 1-Aug-2009.
CrossRef
Myron J. Levin, Roberta L. DeBiasi, Vanda Bostik, and D. Scott Schmid. (2008) Herpes Zoster with Skin Lesions and Meningitis Caused by 2 Different Genotypes of the Oka Varicella‐Zoster Virus Vaccine. The Journal of Infectious Diseases 198:10, 1444-1447
Online publication date: 15-Nov-2008.
Judith Breuer. (2008) Herpes Zoster: New Insights Provide an Important Wake‐Up Call for Management of Nosocomial Transmission. The Journal of Infectious Diseases 197:5, 635-637
Online publication date: 1-Mar-2008.
Adriana S. Lopez, Andrea Burnett‐Hartman, Ram Nambiar, Linda Ritz, Patricia Owens, Vladimir N. Loparev, Dalya Guris, and D. Scott Schmid. (2008) Transmission of a Newly Characterized Strain of Varicella‐Zoster Virus from a Patient with Herpes Zoster in a Long‐Term‐Care Facility, West Virginia, 2004. The Journal of Infectious Diseases 197:5, 646-653
Online publication date: 1-Mar-2008.
Judith Breuer and D. Scott Schmid. (2008) Vaccine Oka Variants and Sequence Variability in Vaccine‐Related Skin Lesions. The Journal of Infectious Diseases 197:s2, S54-S57
Online publication date: 1-Mar-2008.
(2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:9, i-xii
Online publication date: 1-Oct-2007.
CrossRef
D. Scott Schmid, Myron J. Levin, and Vladimir N. Loparev. (2007) Reply to Breuer et al.. The Journal of Infectious Diseases 196:5, 802-803
Online publication date: 1-Sep-2007.
Judith Breuer, Mark Quinlivan, Mahmoud Al Bassam, Susannah Macdonald, Richard A. Nichols, Sharon P. Steinberg, Philip La Russa, and Anne A. Gershon. (2007) DNA Sequence Variability in Oka Vaccine Isolates. The Journal of Infectious Diseases 196:5, 801-802
Online publication date: 1-Sep-2007.
  • Potential conflicts of interest: none reported.

    Presented in entirety: 30th International Herpesvirus Workshop, Turku, Finland, 30 July through 4 August 2005 (abstract 4.17).

    Financial support: National Vaccine Program Office Unmet Needs (grant N25 in 2003); core programmatic funds allocated to the Centers for Disease Control and Prevention.

    All authors contributed equally to this work. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agency.

Close Popup